This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
The presidential election may have ended last week in the U.S., but votes were still being counted for the 2024 edition of the Minnies. With 100% of precincts now reporting, we’re finally ready to declare this year’s winners in our annual awards program recognizing excellence in radiology. Once again, we had a top-notch group of finalists, presenting our expert voting panel with some very difficult decisions.
tim.hodson Tue, 11/12/2024 - 10:17 Nov. 12, 2024 — iCAD, Inc., a provider of clinically proven AI-powered cancer detection solutions, recently announced its ProFound Detection Version 4.0 for Digital Breast Tomosynthesis (DBT) has received clearance from the U.S. Food and Drug Administration (FDA). This next-generation AI solution, trained using advanced deep learning convolutional neural networks (CNN), offers advancements in cancer detection and specificity, achieving a 6.3% improved area unde
Amidst rising cancer prevalence and soaring costs, new cancer technologies and innovations are emerging to support the early detection, treatment, and surveillance of cancer. Read this guide to understand how to evaluate these solutions for your employees and members – and to learn more about the current state of coverage, clinical and cost effectiveness, and impact on quality and outcomes.
Pylarify is is a PSMA-targeted PET agent for pinpointing suspected metastasis or recurrence of prostate cancer, which will be impacted by a new Medicare policy change.
Pylarify is is a PSMA-targeted PET agent for pinpointing suspected metastasis or recurrence of prostate cancer, which will be impacted by a new Medicare policy change.
Welcome to the first installment of this year’s Road to RSNA preview of the RSNA 2024 meeting. We’re once again providing a modality-by-modality overview of select scientific presentations to serve as your guide to events at McCormick Place. Fittingly, our journ ey along the Road to RSNA begins with AI, a topic that has taken center stage at the annual meeting for the past eight years.
Docs at the AMA’s Interim Meeting in Orlando, Florida, have voted to support greater oversight of nonprofit hospitals and to standardize charity care policies.
Sunday, December 1 | 9:10 a.m.-9:20 a.m. | S1-SSCH01-2 | E451A Computing thoracic bone and muscle metrics in patients with chronic obstructive pulmonary disease (COPD) improves understanding of the role of certain comorbidities in COPD disease progression, according to findings to be announced in this scientific presentation. Toward retrospectively characterizing osteoporosis and sarcopenia, researchers applied deep learning-based automated algorithms to inspiratory chest CT images of 1,127 part
As recruiters, we’re well aware that for a candidate, getting the job is only the first step in the journey. In order to excel in the organization, they have to show up to work and feel like they belong. Every human being brings their entire self to work. They are an amalgamation of all of their identity and life experiences. When the culture within an organization is narrow, people can struggle to feel like they fit in.
Patient-centric scheduling can only be achieved through optimized radiology workflows, effective communications between staff and physicians, and, of course, through specialized schedulers. In this guide, we’ll take you through a step-by-step process to transform your radiology center into a high-performance hub of medical imaging.
iCAD has received clearance from the U.S. Food and Drug Administration (FDA) for the latest version of its ProFound Detection software for digital breast tomosynthesis. ProFound Detection 4.0 was trained using advanced deep-learning convolutional neural networks and achieved a 22% overall improvement over the prior version in detecting some of the most challenging and aggressive cancer subtypes, iCAD said.
Add this to the list of things that I should have had ready for launch day back in August: the Independent Radiology Newsletter. Sign up now to receive monthly job updates from the world of private practice radiology. The post IndyRad Newsletter first appeared on Ben White.
GE HealthCare (GEHC) and imaging services provider RadNet have launched a collaboration to further the innovation, commercialization, and adoption of AI in imaging. Initially, GEHC will integrate RadNet’s DeepHealth SmartMammo AI-powered SaaS platform into its Senographe Pristina mammography systems. SmartMammo is designed to improve workflow efficiency in high-volume breast cancer screening programs by prioritizing cases based on suspicion level.
About 40% of us will be diagnosed with cancer in our lifetime, and patients are getting younger. At the same time, the cost of treatment continues to rise, with employers spending 8.5% more on cancer care for each employee than they did last year. The best thing employers can do for their employees and business tomorrow is to invest in cancer detection and care today.
Employing deep learning reconstruction at four excitations for DWI MRI may lead to an average five-minute reduction in exam time for prostate mpMRI, according to a new study.
tim.hodson Tue, 11/12/2024 - 12:06 Nov. 12, 2024 — Enspectra Health recently announced the publication of its cross-modal imaging technology, a method for real-time visualization of skin cellular structure and composition, in Scientific Reports, a journal of the Nature Research family. The publication, titled "Handheld multiphoton and pinhole-free reflectance confocal microscopy enables noninvasive real-time, cross-sectional imaging of skin," was published online.
The Spectral CT 7500 RT system reportedly combines 4D conventional computed tomography (CT) with the enhanced quantification and visualization of spectral CT to facilitate improved precision with radiotherapy.
A new study has highlighted the key atherosclerotic features most strongly linked to major adverse cardiovascular events and revealed that these features are more reliable than traditional clinical risk scores.
Discover how Color's comprehensive care solution is revolutionizing cancer screening adherence and knowledge. Through an in-depth case study, Color's unique approach to comprehensive cancer care has shown significant benefits in increasing screening rates and enhancing patient knowledge. Participants reported a 2-3x increase in adherence to screening guidelines over just 8 weeks, with 84% of participants increasing their familiarity with timing and frequency of cancer screening.
Employing advanced deep learning convolutional neural networks, ProFound Detection Version 4.0 reportedly offers a 50 percent improvement in detecting cancer in dense breasts in comparison to the previous version of the software.
Unconjugated radionuclides offer unique advantages in nuclear medicine, enabling precise imaging and targeted therapies. The post Powering Precision: The Untapped Potential of Unconjugated Radionuclides appeared first on Open MedScience.
Batch reading of digital breast tomosynthesis (DBT) exams can improve the reading performance of radiologists, according to research published November 12 in Radiology. A team led by Craig Abbey, PhD, from the University of California, Santa Barbara found that radiologists achieved improved recall rates and interpretation times without change in sensitivity in batch reading screening DBT exams.
Radionuclide Therapy Effects include potential organ toxicity, requiring careful monitoring to manage patient outcomes effectively. The post Radionuclide Therapy Effects Uncovered: The Hidden Impact on Our Organs appeared first on Open MedScience.
Explore the latest insights from the American Cancer Society's “Cancer Statistics 2024” report, which unveils multiple alarming trends in cancer data. Cancer is on the rise among young adults, and diagnoses for 6 of the 10 most common cancers are escalating. With over 2 million new cancer cases projected in the U.S. this year, employers face increased challenges when it comes to supporting employees.
Royal Philips has received clearance from the U.S. Food and Drug Administration (FDA) for its new detector-based spectral CT radiotherapy (RT) scanner. The Spectral CT 7500 RT integrates the tumor visualization and tissue characterization capabilities of spectral CT into cancer treatment and planning. The system allows radiation oncologists to target radiation therapy to the specific physiological characteristics of a patient's tumor, which minimizes damage to healthy surrounding tissue and redu
Sports medicine combines prevention, treatment, and rehabilitation to support athletes’ performance, health, and resilience. The post Optimising Performance and Recovery: The Science of Sports Medicine appeared first on Open MedScience.
tim.hodson Tue, 11/12/2024 - 10:50 Nov. 11, 2024 — GE HealthCare and DeepHealth, Inc., a wholly-owned subsidiary of RadNet, Inc. have formed a strategic collaboration to further the innovation, commercialization, and adoption of AI in imaging. The companies aim to develop SmartTechnology solutions that harness the power of AI to address key challenges across the imaging value chain, including helping increase the efficiency of imaging interpretation and reporting, enabling collaboration across c
tim.hodson Tue, 11/12/2024 - 11:47 Nov. 11, 2024 — Mach7 Technologies has formally launched UnityVue, a new radiology software platform developed in partnership with NewVue. UnityVue integrates Mach7's eUnity Enterprise Diagnostic Viewer (eUnity) with NewVue's EmpowerSuite Workflow Orchestrator, delivering a comprehensive software platform designed to improve radiology reading workflows.
As HR and Benefits leaders are in the midst of evaluating cancer care solutions and designing their requirements for vendors, it’s key to know what questions to ask to ensure the development of a truly comprehensive strategy: from prevention to diagnosis to treatment to survivorship. Getting to the right answers starts with asking the right questions: How can better access improve engagement?
Input your email to sign up, or if you already have an account, log in here!
Enter your email address to reset your password. A temporary password will be e‑mailed to you.
We organize all of the trending information in your field so you don't have to. Join 5,000 users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
360 
Let's personalize your content